Liquidia Corp LQDA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/24/24 EDT
12.25quote price arrow down-0.17 (-1.37%)
Volume
16,233
Close
12.42quote price arrow down-0.42 (-3.27%)
Volume
531,937
52 week range
5.71 - 16.99
Loading...
  • Open12.85
  • Day High12.95
  • Day Low12.36
  • Prev Close12.84
  • 52 Week High16.99
  • 52 Week High Date03/22/24
  • 52 Week Low5.71
  • 52 Week Low Date10/19/23

Key Stats

  • Market Cap948.673M
  • Shares Out76.38M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change3.24

KEY STATS

  • Open12.85
  • Day High12.95
  • Day Low12.36
  • Prev Close12.84
  • 52 Week High16.99
  • 52 Week High Date03/22/24
  • 52 Week Low5.71
  • 52 Week Low Date10/19/23
  • Market Cap948.673M
  • Shares Out76.38M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change3.24

RATIOS/PROFITABILITY

  • EPS (TTM)-1.57
  • P/E (TTM)-7.92
  • Fwd P/E (NTM)-10.84
  • EBITDA (TTM)-91.453M
  • ROE (TTM)-128.27%
  • Revenue (TTM)15.967M
  • Gross Margin (TTM)76.82%
  • Net Margin (TTM)-674.42%
  • Debt To Equity (MRQ)97.80%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Liquidia Corp

 

Profile

MORE
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operates through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH...
Stephen Bloch
Independent Chairman of the board
Roger Jeffs Ph.D.
Chief Executive Officer, Director
Michael Kaseta
Chief Financial Officer, Chief Operating Officer
Russell Schundler J.D.
General Counsel, Secretary
Address
419 Davis Drive, Suite 100
Morrisville, NC
27560
United States

Top Peers

SYMBOLLASTCHG%CHG
CATX
Perspective Therapeutics Inc
1.50-0.01-0.66%
CNTA
Centessa Pharmaceuticals PLC
8.27-0.08-0.96%
CATX
Perspective Therapeutics Inc
1.50-0.01-0.66%
TYRA
Tyra Biosciences Inc
17.32+0.32+1.88%
SRRK
Scholar Rock Holding Corp
10.67-0.12-1.11%